News › Industry News, News

Could the FDA Sunscreen Monograph See a New Addition?

August 29, 2019

The U.S. Food and Drug Administ­ration (FDA) has just published meeting notes in reference to a proposal by DSM Nutritional Products to add the sunscreen bemotrizinol (up to 10%) as a GRASE ingredient to the OTC Sunscreen Monograph.
In the official memorandum, the FDA calls for the submission of specific data to review within seven to nine months (hopefully), and will then issue a final order classifying bemotrizinol (also known as BEMT) as GRASE or not GRASE.Read more at Skin Inc. >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Advisory Committee Recommends Adding Six of Seven Peptides to Compounding List
    • FDA Advisory Committee Recommends Adding BPC-157 to Compounding List
    • New IV Rules in Maine
    • FDA to Review Peptides: What Med Spa Professionals Should Know Ahead of the July 23–24 Meeting
    • Study Finds Clinics Continue to Prescribe Compounded GLP-1s
Advertisement